Point-of-Care Glucose Testing Market Analysis

Based on product type, the market is segmented into lancing devices, test strips, and blood-glucose meter. The test strips segment of the market is forecasted to reach USD 2.3 billion by 2032.

• Test strips offer high accuracy and precision in glucose measurement, which is essential for effective diabetes management.
  
• Additionally, the user-friendly design of test strips requires minimal training, making them accessible for both patients and healthcare providers. The process involves placing a small blood sample on the strip and inserting it into a glucose meter, facilitating ease of use.
  
• Test strips are relatively inexpensive compared to advanced glucose monitoring technologies, making them a cost-effective option for frequent testing. Their ability to deliver rapid glucose readings is crucial for timely decisions regarding insulin dosing and other management aspects, thereby contributing to market growth.
  

Based on end-use, the point-of-care glucose testing market is bifurcated into hospitals, clinics, diagnostic centers, home care settings, and other end-users. The home care settings segment accounted for USD 1.3 billion in 2023.

• Home care settings offer significant advantages for point-of-care glucose testing. They allow individuals with diabetes to manage their condition conveniently from home, reducing the need for frequent healthcare facility visits.
  
• Moreover, increasing approval from regulatory bodies such as the U.S. FDA for home-based POC glucose testing products is enhancing their availability across the globe, which is contributing to revenue growth in the home care settings segment.
  
• For instance, in March 2024, the U.S. Food and Drug Administration (FDA) approved the Dexcom Stelo Glucose Biosensor System, marking it as the first continuous glucose monitor to be available over-the-counter.
  

The growth of the point-of-care glucose testing market in the U.S., projected to reach USD 1.9 billion by 2032.

• The region has one of the highest prevalence rates of diabetes globally. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2021, over 38.4 million Americans had diabetes, with millions more estimated to have prediabetes. This large patient population drives the demand for diabetes care devices.
  
• The U.S. has a well-established healthcare infrastructure that supports the widespread use of advanced medical technologies, including point-of-care glucose testing devices.
  

The point-of-care glucose testing market in UK is expected to experience significant and promising growth from 2024 to 2032.

• The UK benefits from a well-established and sophisticated healthcare infrastructure. The National Health Service (NHS) provides a comprehensive framework for the integration of new medical technologies, including point-of-care (POC) glucose testing systems.
  
• The UK is a hub for medical research and innovation. Numerous universities and research institutions focus on advancing diagnostic technologies, including glucose monitoring. This research contributes to the development of more accurate, efficient, and user-friendly point-of-care glucose testing devices.
  

Japan point-of-care glucose testing market is anticipated to witness lucrative growth between 2024 – 2032.

• Japan is renowned for its technological advancements and innovation in the medical device sector. Japanese companies are at the forefront of developing cutting-edge glucose monitoring technologies, including non-invasive and minimally invasive devices.
  
• Japan has one of the world’s most rapidly aging populations, which increases the prevalence of diabetes and the demand for effective glucose monitoring solutions. The growing need for efficient diabetes management drives market growth for point-of-care glucose testing devices.
  

The point-of-care glucose testing market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.

• Saudi Arabia is investing significantly in its healthcare infrastructure as part of Saudi Vision 2030, which aims to enhance healthcare services and integrate advanced medical technologies. This investment creates a favorable environment for the adoption of POC glucose testing devices.